ANDROSKAT

This brand name is authorized in Netherlands, United Kingdom

Active ingredients

The drug ANDROSKAT contains a combination of these active pharmaceutical ingredients (APIs):

1 Phentolamine
UNII Z468598HBV - PHENTOLAMINE

Phentolamine is a competitive non-selective α1- and α2-adrenergic receptor blocker of relatively short duration of action. It causes vasodilatation and a fall in blood pressure resulting from the blockade of both post-junctional vascular α1- and α2-adrenoceptors. It also antagonises the vasoconstrictor response to noradrenaline and adrenaline infusions.

Read about Phentolamine
2 Papaveretum
UNII DAA13NKG2Q - PAPAVERINE

Papaveretum is a preparation containing a mixture of hydrochloride salts of opium alkaloids.

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G04BE30 Combinations G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 350127
Country: NL Z-Index G-Standaard Identifier(s): 14077566
Country: NL Z-Index G-Standaard, PRK Identifier(s): 87580

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.